NCT04614545View on ClinicalTrials.gov

Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

August 27, 2021

Study Completion Date

September 29, 2022

Conditions
Obesity
Interventions
DRUG

Phentermine 37.5 Mg

Patients will receive 37.5 mg of phentermine daily for a 12 week duration

BEHAVIORAL

Dietary program

Patients will be able to select either the Mediterranean diet or the Ketogenic diet and will work with a dietician

BEHAVIORAL

Exercise program

Patients will be provided with a personalized exercise program

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT04614545 - Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity | Biotech Hunter | Biotech Hunter